In recognition of #WorldImmunizationWeek , GHTC is highlighting 5⃣ vaccines in development that could be game changers.

ETVAC is an oral vaccine candidate for #ETEC , which has shown promising results in Phase 1 & 2 trials that received partial
funding from PATH. 💉

Also a nasal vaccine for #Marburg that is soon entering clinical trials, funded by BARDA and Department of Defense 🇺🇸, which is urgently needed given recent outbreaks of the disease.

Dr. Gupta from IAVI highlights “germ-line targeting” vaccines in development for #HIV w/ USAID Global Health support and a new TB vaccine in phase 2 trials supported by NIH and Department of Defense 🇺🇸. #globalhealth #innovate4health

. Delali highlights the success of Drugs for Neglected Diseases initiative in bringing 13 new treatments to market for NTDs, including a much improved all-oral treatment for sleeping sickness. #globalhealth #innovate4health

Dr. Lurie of CEPI cites the 8 #Covid19 vaccines CEPI successfully brought to market and exciting vaccines now in clinical development for Lassa, Nipah, and more benefiting from USG support through USAID Global Health.

This slide from GHTC’s report is key - there is no incentive for industry to invest in drugs & vaccines that aren’t profitable (right now). This is where public funding must come in - and with access conditions across the board! #INB #PandemicAccord

Our US Policy Officer Alex Long presents findings for our Doing Well By Doing Good report w/PolicyCuresResearch showing the blockbuster returns from US government investments in #globalhealth R&D. #innovate4health

#healthsecurity is national security said Rep. Mike Levin, emphasizing the importance of innovation to addressing #AMR and preventing future pandemics. #innovate4health

.Ami Bera, M.D. touts the US’s capacity for innovation in #health R&D - next step is expanding access through innovation. Investment is key!

.Ami Bera, M.D. spoke about the promise of TB vaccines in the pipeline and how close we are to polio eradication. #innovate4health

Excited to be on Capitol Hill today to share findings from our Doing Well By Doing Good report with PolicyCuresResearch #innovate4health

As reports of #H5N1 #BirdFlu circulating in dairy cow herds across the United States continue, the experts in charge of preparing and responding to pandemics are now considering our ability to quickly develop a vaccine if human transmission were to occur in the future.

A PDP, also known as an NPPD, is a type of PPP that often employs TPPs for its research. Confused?!? Turn to our #GlobalHealth R&D to decode these acronyms. 👉

In recognition of #WorldImmunizationWeek , GHTC is highlighting 5⃣ vaccines in development that could be game changers.

The first human trial of a new vaccine against the deadly #Nipah virus began in January of this year. 💉

What's new in #GlobalHealth R&D?
🐄 #H5N1 #BirdFlu preparedness
🥼 #Malaria medicine for babies
💊 #VisceralLeishmaniasis drug

#WorldMalariaDay is over but the fight to #EndMalaria continues!

Learn more about this deadly disease and the innovations being advanced to combat it with our quiz!

In recognition of #WorldImmunizationWeek , GHTC is highlighting 5⃣ vaccines in development that could be game changers.

The first participants were recently vaccinated in a Phase 2 trial of a vaccine candidate for #LassaFever virus led by partners IAVI & CEPI. 💉

New technologies have driven tremendous progress in #GlobalHealth , but major gaps remain in our arsenal of tools needed to bring an end to the world’s most devastating diseases. 🔬💉💊Learn more in our fact sheet series! ⬇️ #Innovate4Health

🦟 This #WorldMalariaDay , we celebrate the crucial role of vector control in malaria elimination. We drive collaboration to develop innovative tools like indoor residual sprays, combating insecticide resistance.

Malaria is one of humanity’s oldest foes. What will it take to defeat it? New vaccines, coupled with other preventive tactics, will be key. #WorldMalariaDay asm.social/1Px